Novartis launches rival to EpiPen for allergy emergencies amid shortage in U.S.

By Thomson Reuters ·

Both adult and pediatric doses of Symjepi to be available immediately

Sandoz

Symjepi delivers epinephrine, a critical medicine in the event of severe allergic reactions.

A unit of Novartis AG said it would make partner Adamis Pharmaceuticals Corp's emergency allergy shots immediately available in local pharmacies across the United States, amid a U.S. shortage of Mylan NV's rival product, EpiPen.

More at Health - CBC